Petros Family Wealth LLC acquired a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) during the 4th quarter, HoldingsChannel.com reports. The firm acquired 617 shares of the biotechnology company’s stock, valued at approximately $367,000.
A number of other hedge funds and other institutional investors have also recently modified their holdings of AXON. Kovitz Investment Group Partners LLC bought a new position in shares of Axon Enterprise during the 3rd quarter valued at approximately $328,000. Orion Portfolio Solutions LLC lifted its position in Axon Enterprise by 1.3% during the third quarter. Orion Portfolio Solutions LLC now owns 3,134 shares of the biotechnology company’s stock valued at $1,252,000 after purchasing an additional 39 shares during the last quarter. Nomura Asset Management Co. Ltd. increased its holdings in shares of Axon Enterprise by 6.8% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 21,104 shares of the biotechnology company’s stock worth $8,433,000 after buying an additional 1,347 shares during the last quarter. Sanctuary Advisors LLC raised its position in shares of Axon Enterprise by 1,164.3% during the 3rd quarter. Sanctuary Advisors LLC now owns 34,301 shares of the biotechnology company’s stock valued at $13,707,000 after buying an additional 31,588 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new position in shares of Axon Enterprise in the 3rd quarter valued at about $759,000. Institutional investors own 79.08% of the company’s stock.
Axon Enterprise Trading Up 3.0 %
NASDAQ AXON opened at $567.98 on Friday. The stock has a market cap of $43.52 billion, a PE ratio of 146.77, a PEG ratio of 5.17 and a beta of 1.13. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The company’s 50-day moving average price is $567.07 and its 200-day moving average price is $560.54. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.
Analyst Upgrades and Downgrades
Get Our Latest Stock Analysis on AXON
Insiders Place Their Bets
In related news, Director Jeri Williams sold 307 shares of the business’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 6.10% of the company’s stock.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
- Five stocks we like better than Axon Enterprise
- 3 REITs to Buy and Hold for the Long Term
- JPMorgan is a Buy, if You Can Handle The Volatility
- Dividend Payout Ratio Calculator
- United States Steel’s Crash: An Unmissable Buying Opportunity
- How to Invest in the Best Canadian Stocks
- Rocket Lab Stock: Weathering the Storm, Time for a Comeback?
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.